Opens in a new tab

La Siddhi Consultancy v Athena Pharmaceutiques (CFI, 19 May 2026)

Date19 May 2026
CourtCFI
DivisionMilan (IT) Central Division- Section
Type of actionRevocation Action
Case number(s)UPC_CFI_927/2025
Registry referenceUPC-CFI-0000927/2025
PartiesLa Siddhi Consultancy Limited v. Athena Pharmaceutiques SAS, Substipharm

Official decision (PDF) · UPC registry entry

Case timeline

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By order of 19 May 2026 (UPC_CFI_927/2025), the panel of the Milan Central Division ruled on the confidentiality application by La Siddhi Consultancy, claimant in the revocation action against unitary patent EP 3 592 333 brought against Athena Pharmaceutiques and Substipharm, concerning exhibit MW21, a non-public agreement with a third party filed to show that the claimant is « concerned » by the patent under Art. 47(6) UPCA. It refused an external-representatives-only regime and admitted, on the defendants’ side, their head of legal and one Indian counsel.

Question

Can a party obtain that access to a confidential exhibit be limited to the other side’s external representatives only, and who may be admitted to the confidentiality club?

Decision

In line with the Court of Appeal’s case law (Sun v Vivo), the party concerned must be able to designate at least one natural person, employment by the party being no ground for exclusion. An « external eyes only » regime requires exceptional circumstances, not shown here, the exhibit going to an admissibility issue the defendants are entitled to address (paragraphs 18 and 22 to 30). The auxiliary request is granted: access is limited to the external representatives, the head of legal of the first defendant and a single Indian counsel already involved in the case, a second person not being justified (paragraphs 31 to 41). Experts must be named in a reasoned application (paragraphs 42 to 44). Leave to appeal is granted to both sides.

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts 47(6), 54 and 58
Rules of Procedure
Rules 262, 262A and 220.2
Directive 2004/48/EC
Art. 9(3)
Case law cited
Daedalus Prime v Xiaomi, Court of Appeal, 12 February 2025, NST v Qualcomm, Court of Appeal, 3 July 2025, Sun Patent Trust v Vivo, Court of Appeal, 26 January 2026, Ericsson v Asustek, Milan Local Division, 28 April 2025

Related decisions

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Decisions in the same proceedings

Going further

Lexicon: Revocation action.

Publications by Matthieu Dhenne: G 1/25, Take Three: Anything You Leave in the Description May Be Used Against You (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CFI_927/2025 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

  1. 13 March 2026 La Siddhi Consultancy v Athena Pharmaceutiques (CFI, 13 March 2026) Revocation Action · UPC_CFI_927/2025

    La Siddhi Consultancy doit fournir sous six semaines une garantie de 75 000 euros pour les frais des défenderesses, sa situation financière faisant craindre un défaut de recouvrement et son statut de PME n'étant pas établi. L'autorisation d'appel est accordée.

  2. 19 May 2026 La Siddhi Consultancy v Athena Pharmaceutiques (CFI, 19 May 2026) Revocation Action · UPC_CFI_927/2025

What the record states

Nature of the act
Revocation Action
Outcome (Dhenne Avocats summary)
Le régime « external eyes only » demandé pour un accord produit au soutien de la qualité à agir est refusé. L'accès est ouvert, côté défenderesses, aux représentants externes, à leur directeur juridique et à un conseil indien.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 592 333Mentioned in the analysis (role not qualified)
Also mentioned in 3 other decision(s): La Siddhi Consultancy v Athena Pharmaceutiques (CoA, 1 June 2026) · La Siddhi Consultancy v Athena Pharmaceutiques (CoA, 14 April 2026) · La Siddhi Consultancy v Athena Pharmaceutiques (CFI, 13 March 2026)
not recordednot recordednot recordedEspacenet
links not checked
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.